For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

University of Leeds

Return to search Previous output Next output
Output 128 of 347 in the submission
Article title

First-line therapy for ovarian cancer with carboplatin followed by paclitaxel–gemcitabine (SCOTROC5): A feasibility study and comparative analysis of the SCOTROC series

Type
D - Journal article
Title of journal
European Journal of Cancer
Article number
-
Volume number
46
Issue number
11
First page of article
2020
ISSN of journal
1879-0852
Year of publication
2010
URL
-
Number of additional authors
11
Additional information

"The author made a substantial contribution to the organisation and conduct of the study"

"The author made a substantial contribution to carrying out the study (including acquisition of study data)"

"The author made a substantial contribution to analysis and interpretation of study data"

"The author helped critique the output for important intellectual content"

Interdisciplinary
-
Cross-referral requested
-
Research group
A - Cancer
Citation count
2
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-